Business
from24/7 Wall St.
5 days agoIs It Too Late to Buy GSK After a 46% Share Price Jump?
GSK stock surged 44% in a year but remains undervalued at 14.6x trailing P/E with strong pipeline catalysts and 3.27% dividend yield, though forward P/E of 21.41x reflects execution risk.